This inventor holds 4 USPTO granted patents. Top assignee: Shionogi Company Limited. Active years: 1986-1992.
Company Filing History:
Years Active: 1986-1992
Title: Kunihiro Nakajima: Innovator in Medical Diagnostics
Introduction
Kunihiro Nakajima is a prominent inventor based in Nara, Japan. He has made significant contributions to the field of medical diagnostics, particularly through his innovative patents. With a total of 4 patents, Nakajima's work has had a profound impact on the diagnosis of various health conditions.
Latest Patents
One of Nakajima's latest patents is a method for the determination of N-acetyl-.beta.-D-glucosaminidase (NAGase) activity. This highly sensitive reagent allows for the colorimetric determination of NAGase activity using sodio-3,3'-dichlorophenolsulfonphthaleinyl N-acetyl-.beta.-D-glucosaminide and a buffer. This method enables precise, quick, and easy diagnosis of renal dysfunction. Another notable patent involves the development of anti-HBs monoclonal antibodies, which include HBs 8Cl, HBs 18E9, and HBs 22B7. This invention provides a method for inhibiting nonspecific reactions in reverse passive agglutination, enhancing the accuracy of assays for HBs antigen.
Career Highlights
Kunihiro Nakajima is associated with Shionogi Company Limited, where he continues to advance his research and innovations. His work has been instrumental in developing diagnostic tools that improve patient care and outcomes.
Collaborations
Nakajima has collaborated with notable colleagues, including Akihiko Sato and Akira Noto. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Kunihiro Nakajima's contributions to medical diagnostics through his patents demonstrate his commitment to improving healthcare. His innovative methods and collaborations continue to pave the way for advancements in the field.